844 filings
Page 4 of 43
8-K
ENVB
Enveric Biosciences Inc
14 Aug 23
Enveric Biosciences Reports Second Quarter 2023 Corporate and Financial Results
8:00am
10-Q
2023 Q2
ENVB
Enveric Biosciences Inc
Quarterly report
11 Aug 23
5:11pm
8-K
ENVB
Enveric Biosciences Inc
24 Jul 23
Enveric Biosciences Reports Positive Results from Preclinical Studies Supporting Metabolic Profile of Lead Candidate EB-373
8:15am
8-K
ENVB
Enveric Biosciences Inc
17 Jul 23
Enveric Biosciences Reports Positive Results from Animal Studies Demonstrating Oral
8:15am
UPLOAD
ENVB
Enveric Biosciences Inc
5 Jul 23
Letter from SEC
12:00am
CORRESP
ENVB
Enveric Biosciences Inc
8 Jun 23
Correspondence with SEC
12:00am
8-K
ENVB
Enveric Biosciences Inc
7 Jun 23
Regulation FD Disclosure
8:00am
8-K
ENVB
Enveric Biosciences Inc
6 Jun 23
Regulation FD Disclosure
4:30pm
8-K
ENVB
Enveric Biosciences Inc
5 Jun 23
Enveric Biosciences Receives Notice of Allowance from USPTO for EVM301 Series of Drug Candidates
8:00am
8-K
ENVB
Enveric Biosciences Inc
30 May 23
Enveric Biosciences Announces Poster Presentation at Canadian Neuroscience Meeting 2023
8:00am
8-K
ENVB
Enveric Biosciences Inc
24 May 23
Termination of a Material Definitive Agreement
8:00am
8-K
ENVB
Enveric Biosciences Inc
24 May 23
Regulation FD Disclosure
8:00am
8-K
ENVB
Enveric Biosciences Inc
22 May 23
Regulation FD Disclosure
8:00am
8-K
ENVB
Enveric Biosciences Inc
19 May 23
Enveric Biosciences to Participate in 2023 BIO International Convention in Boston
8:00am
8-K
ENVB
Enveric Biosciences Inc
18 May 23
Enveric Biosciences Receives Notice of Allowance from USPTO for Novel Prodrug of Psilocin
8:00am
10-Q
2023 Q1
ENVB
Enveric Biosciences Inc
Quarterly report
15 May 23
9:25am
UPLOAD
ENVB
Enveric Biosciences Inc
15 May 23
Letter from SEC
12:00am
D/A
ENVB
Enveric Biosciences Inc
19 Apr 23
$12.78 mm in equity / options / securities to be acquired, sold $12.78 mm, 2 investors
4:05pm
8-K
ENVB
Enveric Biosciences Inc
13 Apr 23
Regulation FD Disclosure
8:30am